Overexpression of <i>HIPK2</i> removes the transrepression of proapoptotic genes mediated by the CtBP1-p300-FOXO3a complex and increases the chemosensitivity in osteosarcoma cells

Duan, Ning; Zhang, Wentao; Li, Zhong; Sun, Liang; Song, Tao; Yu, Zirui; Chen, Xun; Ma, Wei

doi:10.7150/jca.52115



International Journal of Biological Sciences

International Journal of Medical Sciences

Theranostics

Journal of Genomics

Nanotheranostics

Global reach, higher impact

Full Text | PDF

J Cancer 2021; 12(6):1826-1837. doi:10.7150/jca.52115 This issue Cite

Research Paper

Overexpression of HIPK2 removes the transrepression of proapoptotic genes mediated by the CtBP1-p300-FOXO3a complex and increases the chemosensitivity in osteosarcoma cells

Ning Duan^1,2#, Wentao Zhang^2#, Zhong Li², Liang Sun², Tao Song², Zirui Yu², Xun Chen^2✉, Wei Ma^1✉

1. Department of Orthopedics, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China.
2. Department of Orthopedic Surgery, Honghui Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi, 710054, China.
#These authors contributed equally to this work.

Citation:

Duan N, Zhang W, Li Z, Sun L, Song T, Yu Z, Chen X, Ma W. Overexpression of HIPK2 removes the transrepression of proapoptotic genes mediated by the CtBP1-p300-FOXO3a complex and increases the chemosensitivity in osteosarcoma cells. J Cancer 2021; 12(6):1826-1837. doi:10.7150/jca.52115. https://www.jcancer.org/v12p1826.htm

Other styles

Abstract

Decreased expression of proapoptotic genes can lead to the chemoresistenance in cancer therapy. Carboxyl-terminal binding protein 1 (CtBP1), a transcriptional corepressor with multiple oncogenic effects, has been previously identified to suppress the expression of two proapoptotic genes [BAX (BCL2 associated X) and BIM (Bcl-2 interacting mediator of cell death)] by assembling a complex with the Forkhead box O3 (FOXO3a) transcription factor and the p300 histone acetyltransferase. However, the upstream regulatory signaling of the CtBP1-p300-FOXO3a complex is obscure, and the effects of changing this signaling on chemosensitivity in osteosarcoma are unknown. Herein, we discovered that the downregulation of HIPK2 (Homeodomain-interacting protein kinase 2) was essential for the function of the CtBP1-p300-FOXO3a complex. Downregulation of HIPK2 prevented the phosphorylation and subsequent degradation of CtBP1, thereby allowing the assembly of the CtBP1-p300-FOXO3a complex and suppression of the expression of proapoptotic genes, such as BAX, BIM, BIK (Bcl-2 interacting killer) and NOXA/PMAIP1 (Phorbol-12-myristate-13-acetate-induced protein 1). Overexpression of HIPK2 promoted the phosphorylation of CtBP1 and the degradation of CtBP1 by proteasomes, thereby preventing the formation of the CtBP1-p300-FOXO3a complex. The abolition of CtBP1 transrepression increased the expression of proapoptotic genes to induce apoptosis and increase chemosensitivity in osteosarcoma cells. Taken together, our in vitro and in vivo results revealed that overexpression of HIPK2 could remove the CtBP1-mediated transrepression of proapoptotic genes, indicating a new therapeutic option for the treatment of osteosarcoma.

Keywords: CtBP1, HIPK2, proapoptotic genes, chemosensitivity, osteosarcoma

Citation styles

APA

Duan, N., Zhang, W., Li, Z., Sun, L., Song, T., Yu, Z., Chen, X., Ma, W. (2021). Overexpression of HIPK2 removes the transrepression of proapoptotic genes mediated by the CtBP1-p300-FOXO3a complex and increases the chemosensitivity in osteosarcoma cells. Journal of Cancer, 12(6), 1826-1837. https://doi.org/10.7150/jca.52115.

ACS

Duan, N.; Zhang, W.; Li, Z.; Sun, L.; Song, T.; Yu, Z.; Chen, X.; Ma, W. Overexpression of HIPK2 removes the transrepression of proapoptotic genes mediated by the CtBP1-p300-FOXO3a complex and increases the chemosensitivity in osteosarcoma cells. J. Cancer 2021, 12 (6), 1826-1837. DOI: 10.7150/jca.52115.

NLM

CSE

Duan N, Zhang W, Li Z, Sun L, Song T, Yu Z, Chen X, Ma W. 2021. Overexpression of HIPK2 removes the transrepression of proapoptotic genes mediated by the CtBP1-p300-FOXO3a complex and increases the chemosensitivity in osteosarcoma cells. J Cancer. 12(6):1826-1837.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.